Nermin S Ahmed

9PUBLICATIONS
19CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersReaction engineering (excl. nuclear reactions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 20, 2026
Effect of Stereochemistry on the Antiplasmodial Activity and Metabolomic Profile of Novel Tadalafil Analogues.

|Aug 21, 2025
Design and Synthesis of Potent Ridaifen Analogues: Evaluation as Anticancer, 20S Proteasomal Inhibitors, and Antiebola Virus Agents through In vitro and In Silico Studies.

Merna A Vector, Sae Fujiwara, Yunhao Zhu

|Aug 14, 2025
CCR4-NOT Transcription Complex Subunit 7 (CNOT7) Protein and Leukocyte-Associated Immunoglobulin-like Receptor-1 in Breast Cancer Progression: Clinical Mechanistic Insights and In Silico Therapeutic Potential.

Mona M Elanany, Dina Mostafa, Ahmad A Hady

|Nov 08, 2023
Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability.

Mirja Harms, Rikke Fabech Hansson, Andrea Gilg

|Oct 25, 2023
Design, synthesis, and in-silico study of novel triarylethylene analogs with dual anti-estrogenic and serotonergic activity.

Tammy Mostafa, Miriam Albeir, Jannette Wober

|Jul 31, 2023
Structure-Activity Relationships of Triphenylethylene Derivatives and Their Evaluation as Anticancer and Antiviral Agents.

Nermin S Ahmed, Heba E El-Nakib, Marian M Ramsis

Pageof 2

Frequent Collaborators

4 joint publications

Ashraf H Abadi

2 joint publications

Jan J Weigand

2 joint publications

Kai Schwedtmann

1 joint publications

Mirja Harms